2nd Quarter - Report
THE SIMMONS & RUSSELL GROUP, LLC for ELI LILLY AND COMPANY
Client
Income
$60,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Monitoring pharmaceutical issues in the Better Care Reconciliation Act of 2017. Monitoring pharmaceutical issues in the FDA Reauthorization Act of 2017, S.934. Issues related to drug pricing and value.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT A RUSSELL | — |
| KYLE SIMMONS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.